Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: The standard malaria rapid diagnostic test (RDT) and newer ultra-sensitive RDT (uRDT) target Plasmodium falciparum histidine rich protein-2 (HRP2), which persists post-treatment. The duration of test positivity has not previously been studied in a low transmission setting.
Methods: We conducted a longitudinal cohort study in a low transmission setting in Namibia. RDT-positive individuals identified through passive and active case detection were treated and followed weekly for testing by RDT and uRDT, HRP2 quantification, quantitative PCR (qPCR) of parasitemia, and quantitative reverse transcriptase PCR (RT-PCR) of gametocytemia, until RDT and uRDT were negative for two consecutive weeks. Determinants of persistent positivity were identified using Cox proportional hazards models.
Findings: Among 137 participants with complete follow-up and no evidence of resurgence during follow-up, median duration of positivity was 42 days (range: 3-98 range) for RDT, compared to 67 days (range 12-105) for uRDT. In a sub-analysis of those with laboratory data before treatment (n = 60), drug resistance did not explain persistent positivity. Younger age (<15 years versus ≥15 years: aHR: 1.85, 95% CI 1.04-3.30, and 1.67, 95% CI 0.96-2.89, for RDT and uRDT, respectively), higher initial parasite density (highest versus lowest tertile: aHR 0.11, 95% CI 0.04-0.32 and 0.19, 95% CI 0.07-0.48 for RDT and uRDT, respectively), and persistent parasitemia (≥7 days versus reference of <7 days, aHR 0.39, 95% CI 0.20-0.76, and 0.40, 95% CI 0.21-0.76 for RDT and uRDT, respectively) were associated with longer duration of positivity.
Interpretation: Duration of RDT/uRDT positivity was more than double compared to reports from higher endemic settings, potentially due to lower population immunity to clear parasite DNA and antigen. Prolonged duration of positivity compromises their use to detect current infection, but increased detection of recent infection can facilitate surveillance and inform elimination efforts.
Funding: The project was funded by the Bill and Melinda Gates Foundation (A128488 and INV1135840), Horchow Family Fund (5300375400), and Chan Zuckerberg Biohub.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11683224 | PMC |
| http://dx.doi.org/10.1016/j.ebiom.2024.105489 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Post-treatment duration of positivity for standard and ultra-sensitive Plasmodium falciparum antigen-based rapid diagnostic tests, a cohort study from a low-endemic setting in Namibia.
EBioMedicine
January 2025
Malaria Elimination Initiative, Global Health Group, University of California, San Francisco (UCSF), San Francisco 94158, USA; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75390, USA; Department of Pediatrics, UCSF Benioff Children's Hospital, San Francisco 94158
Article Synopsis
- - The study investigated how long malaria rapid diagnostic tests (RDT) and ultra-sensitive RDT (uRDT) remained positive after treatment in a low transmission area in Namibia, finding an average positivity duration of 42 days for RDT and 67 days for uRDT.
- - Factors such as younger age, higher initial parasite density, and persistent parasitemia were linked to longer test positivity, indicating that the usual explanations for lingering positive results, like drug resistance, did not apply.
- - These prolonged positivity durations highlight challenges in using RDTs and uRDTs for accurately identifying current infections in low transmission settings, as they might reflect residual parasite DNA rather than active infection.
Diagnostic performance of an ultra-sensitive RDT and a conventional RDT in malaria mass testing, treatment and tracking interventions in southern Ghana.
Parasit Vectors
July 2024
Department of Epidemiology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
Article Synopsis
- The study focuses on the role of asymptomatic malaria carriers in sustaining transmission and compares the effectiveness of two different diagnostic tests (uRDT and cRDT) for detecting asymptomatic malaria in Ghana over a year.
- Researchers tested 4,000 participants in two towns, and through mass testing and treatment initiatives, they tracked the impact on malaria prevalence.
- Results showed that while the intervention site saw a significant decrease in asymptomatic parasite prevalence, the control site did not experience a notable change, and the models indicated the impact of diagnosis sensitivity and human movement on the effectiveness of the interventions.
Performance of ultra-sensitive malaria rapid diagnostic test to detect Plasmodium falciparum infection in pregnant women in Kinshasa, the Democratic Republic of the Congo.
Malar J
October 2023
Department of Tropical Medicine, University of Kinshasa (UNIKIN), Kinshasa, Democratic Republic of the Congo.
Background: Low peripheral parasitaemia caused by sequestration of Plasmodium falciparum in the placenta hampers the diagnosis of malaria in pregnant women, leading to microscopy or conventional rapid diagnostic tests (RDTs) false-negative results. Although mainly asymptomatic, maternal malaria remains harmful to pregnant women and their offspring in endemic settings and must be adequately diagnosed. Ultra-sensitive RDTs (uRDTs) are thought to be more sensitive than RDTs, and their diagnostic performance was assessed in the current study in pregnant women living in Kinshasa, a stable malaria transmission area in the Democratic Republic of the Congo.
View Article and Find Full Text PDFMalaria in pregnancy (MiP) studies assessing the clinical performance of highly sensitive rapid diagnostic tests (HS-RDT) for Plasmodium falciparum detection.
Malar J
February 2023
FIND, Geneva, Switzerland.
Article Synopsis
- Rapid diagnostic tests (RDTs) are crucial for detecting malaria, especially in pregnancy, and a new highly sensitive rapid diagnostic test (HS-RDT) shows promise for improving diagnosis and outcomes in malaria-endemic regions.
- A review of thirteen studies comparing HS-RDT with conventional RDT (co-RDT) and molecular methods found varying sensitivity rates for both tests, with HS-RDT generally performing better in detecting low parasite densities.
- Despite its higher analytical sensitivity, the clinical advantages of HS-RDT over co-RDT were marginal and not statistically significant, indicating a need for further research to fully assess the benefits of RDT improvements.
Persistence of Plasmodium falciparum HRP-2 antigenaemia after artemisinin combination therapy is not associated with gametocytes.
Malar J
December 2022
Malaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali.
Background: In some settings, sensitive field diagnostic tools may be needed to achieve elimination of falciparum malaria. To this end, rapid diagnostic tests (RDTs) based on the detection of the Plasmodium falciparum protein HRP-2 are being developed with increasingly lower limits of detection. However, it is currently unclear how parasite stages that are unaffected by standard drug treatments may contribute to HRP-2 detectability and potentially confound RDT results even after clearance of blood stage infection.
View Article and Find Full Text PDF